NCF1 and chronic granulomatous disease: For example, mutations in p47phox Site 2 including R42W/Q, E46K, E49K and of PIP-stop residue T48C are associated with chronic granulomatous disease and prostate, kidney, skin and intestinal cancer [13,129,130].